Table 4.
Group A | |||
Pathology | Telemedicine | Type | Outpatient Treatment/Service |
SubGroup A1
Neoplasm Follow-up |
54 contacts | Head & neck Carcinoma: 54 | Clinical control: 7 |
Advanced dressing: 3 | |||
Biopsy: 5 | |||
SubGroup A2 Other Control/Follow-Up |
9 contacts | Pre-cancerous: 6 | |
MRONJ: 3 | |||
Group B | |||
Pathology | Telemedicine | Type | Outpatient Treatment/Service |
SubGroup B1 Neoplasm 1st visit |
12 contacts | Skin Carcinoma: 3 | Skin Biopsy: 2 |
Mucosa Oral Carcinoma: 8 | Oral Biopsy: 4 | ||
Submandibular gland Carcinoma: 1 | |||
SubGroup B2 Other 1st visit |
15 contacts | MRONJ: 7 | MRONJ: 3 |
TMJ Dislocation: 2 | TMJ Dislocation: 2 | ||
Odontogenic abscess: 3 | Odontogenic abscess: 1 | ||
Sialoadenitis: 3 |